MedTrace Logo

CAR-T Treatment in Pediatric and Adult Acute Lymphoblastic Leukemia

NCT07623655 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 107

Last updated 2026-06-03

No results posted yet for this study

Summary

The goal of this observational study is to evaluate the efficacy of the treatment with approved CAR-T cells in Italy in pediatric and adult patients with acute B-cell lymphoblastic leukemia. The main question it aims to answer is:

which is the overall response rate in pediatric and adult patients with acute B-cell lymphoblastic leukemia treated with approved CAR-T cells?

Data will be extracted from patients medical records.

Conditions

Sponsors & Collaborators

  • Gruppo Italiano Malattie EMatologiche dell'Adulto

    lead OTHER

Principal Investigators

  • Federico Lussana · Ospedale Papa Giovanni XXIII, Bergamo

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-09-01
Primary Completion
2029-09-01
Completion
2029-12-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07623655 on ClinicalTrials.gov